As filed with the Securities and Exchange Commission on August 26, 2008.

Registration No. 333-                          

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

 


 

FORM S-8

 

REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

 


 

Abbott Laboratories

(Exact name of registrant as specified in its charter)

 

Illinois

 

36-0698440

(State or other jurisdiction of

 

(I.R.S. Employer

incorporation or organization)

 

Identification No.)

 

 

 

Abbott Laboratories

 

 

100 Abbott Park Road

 

 

Abbott Park, Illinois

 

60064-6400

(Address of Principal Executive Offices)

 

(Zip Code)

 

ABBOTT LABORATORIES DEFERRED COMPENSATION PLAN

(Full title of the plan)

 


 

Laura J. Schumacher

Abbott Laboratories

100 Abbott Park Road

Abbott Park, Illinois 60064-6400

(Name and address of agent for service)

 

Telephone number, including area code, of agent for service:  (847) 937-6100

 


 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer

x

Accelerated filer

o

Non-accelerated filer

o

Smaller reporting company

o

(Do not check if a smaller reporting company)

 

 

 


 

CALCULATION OF REGISTRATION FEE

 

Title of securities to
be registered

 

Amount to be
registered

 

Proposed
maximum offering
price per share (a)

 

Proposed maximum
aggregate offering
price (a)

 

Amount of
registration fee (a)

 

Deferred Obligations

 

$

60,000,000

 

N/A

 

$

60,000,000

 

$

2,358

 

(a)           The deferred obligations are unsecured obligations of Abbott Laboratories to pay deferred compensation in the future in accordance with the terms of the Abbott Laboratories Deferred Compensation Plan.

 

 



 

Pursuant to General Instruction E, the contents of Abbott Laboratories Non-Qualified Deferred Compensation Plan Registration Statement on Form S-8 (File no. 333-74220) are incorporated herein by reference.

 

Part II.  Information Required in the Registration Statement

 

Item 8.  Exhibits

 

See Exhibit Index, which is incorporated herein by reference.

 

2



 

SIGNATURES

 

THE REGISTRANT.  Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in unincorporated Lake County, and State of Illinois, on August 25, 2008.

 

 

ABBOTT LABORATORIES

 

 

 

 

 

By:

/s/ Miles D. White

 

            Miles D. White,

 

            Chairman of the Board and

 

            Chief Executive Officer

 

3



 

Each person whose signature appears below constitutes and appoints Miles D. White and Laura Schumacher, Esq., and each of them, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this registration statement, and to file the same with all exhibits thereto, and other documents in connection therewith, with the Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each act and thing requisite and necessary to be done, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

 

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature

 

Title

 

Date

 

 

 

 

 

 

 

 

 

 

/s/ Miles D. White

 

Chairman of the Board,

 

August 25, 2008

Miles D. White

 

Chief Executive Officer, and

 

 

 

 

Director

 

 

 

 

 

 

 

/s/ Thomas C. Freyman

 

Executive Vice President, Finance and

 

August 25, 2008

Thomas C. Freyman

 

Chief Financial Officer (Principal

 

 

 

 

Financial Officer)

 

 

 

 

 

 

 

/s/ Greg W. Linder

 

Vice President and Controller

 

August 25, 2008

Greg W. Linder

 

(Principal Accounting Officer)

 

 

 

 

 

 

 

 

 

 

 

 

/s/ Roxanne S. Austin

 

Director

 

August 25, 2008

Roxanne S. Austin

 

 

 

 

 

 

 

 

 

 

 

 

 

 

/s/ William M. Daley

 

Director

 

August 25, 2008

William M. Daley

 

 

 

 

 

 

 

 

 

 

 

 

 

 

/s/ W. James Farrell

 

Director

 

August 25, 2008

W. James Farrell

 

 

 

 

 

 

 

 

 

 

 

 

 

 

/s/ H. Laurance Fuller

 

Director

 

August 25, 2008

H. Laurance Fuller

 

 

 

 

 

 

 

 

 

 

 

 

 

 

/s/ William A. Osborn

 

Director

 

August 25, 2008

William A. Osborn

 

 

 

 

 

4



 

/s/ David A. L. Owen

 

Director

 

August 25, 2008

David A. L. Owen

 

 

 

 

 

 

 

 

 

 

 

 

 

 

/s/ Boone Powell Jr.

 

Director

 

August 25, 2008

Boone Powell Jr.

 

 

 

 

 

 

 

 

 

/s/ W. Ann Reynolds

 

Director

 

August 25, 2008

W. Ann Reynolds

 

 

 

 

 

 

 

 

 

 

 

 

 

 

/s/ Roy S. Roberts

 

Director

 

August 25, 2008

Roy S. Roberts

 

 

 

 

 

 

 

 

 

 

 

 

 

 

/s/ Samuel C. Scott III

 

Director

 

August 25, 2008

Samuel C. Scott III

 

 

 

 

 

 

 

 

 

 

 

 

 

 

/s/ William D. Smithburg

 

Director

 

August 25, 2008

William D. Smithburg

 

 

 

 

 

 

 

 

 

 

 

 

 

 

/s/ Glenn F. Tilton

 

Director

 

August 25, 2008

Glenn F. Tilton

 

 

 

 

 

5



 

EXHIBIT INDEX

 

Exhibit No.

 

Description

 

 

 

5

 

Opinion of Mayer Brown LLP.

 

 

 

23.1

 

Consent of Mayer Brown LLP is included in the opinion filed as Exhibit 5 hereto.

 

 

 

23.2

 

Consent of Deloitte & Touche LLP.

 

 

 

23.3

 

Consent of Deloitte & Touche LLP.

 

 

 

24

 

Power of Attorney is included on the signature page.

 

6